NBI components
The NASDAQ Biotechnology constituents can be found in the table below. Sort NBI stock components by various financial metrics and data such as performance, dividends, income statement and balance sheet.
Symbol | Market cap | Price | Change % | Volume | Rel Volume | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst Rating |
|---|---|---|---|---|---|---|---|---|---|---|---|
 AZNAstraZeneca PLCDR | 225.37 B USD | 72.60 USD | −1.22% | 3.25 M | 0.73 | 32.22 | 2.25 USD | +18.08% | 2.07% | Health technology | Strong buy |
 AMGNAmgen Inc. | 164.88 B USD | 306.92 USD | −1.49% | 2.84 M | 0.93 | 40.67 | 7.55 USD | −39.56% | 2.93% | Health technology | Buy |
 GILDGilead Sciences, Inc. | 138.58 B USD | 111.28 USD | −0.69% | 6.28 M | 0.58 | 303.13 | 0.37 USD | −91.85% | 2.75% | Health technology | Buy |
 SNYSanofiDR | 135.11 B USD | 54.34 USD | −2.02% | 2.64 M | 1.08 | 22.70 | 2.39 USD | +3.07% | 2.67% | Health technology | Buy |
 VRTXVertex Pharmaceuticals Incorporated | 124.48 B USD | 484.74 USD | −0.02% | 1.24 M | 0.88 | — | −2.20 USD | −115.85% | 0.00% | Health technology | Buy |
 REGNRegeneron Pharmaceuticals, Inc. | 67.45 B USD | 617.00 USD | −2.72% | 1.06 M | 1.11 | 16.12 | 38.29 USD | +10.17% | 0.14% | Health technology | Buy |
 ARGXargenx SEDR | 35.54 B USD | 567.09 USD | −4.19% | 451.22 K | 1.47 | 44.46 | 12.76 USD | — | 0.00% | Health technology | Strong buy |
 ALNYAlnylam Pharmaceuticals, Inc. | 33.27 B USD | 255.76 USD | −5.28% | 861.84 K | 0.69 | — | −2.17 USD | +39.03% | 0.00% | Health technology | Buy |
 ONCBeiGene, Ltd.DR | 31.24 B USD | 271.04 USD | −0.42% | 904.24 K | 2.16 | — | −6.13 USD | +27.88% | 0.00% | Health technology | Strong buy |
 BNTXBioNTech SEDR | 21.85 B USD | 90.29 USD | −0.85% | 1.13 M | 1.23 | — | −3.04 USD | −174.06% | 0.00% | Health technology | Buy |
 BIIBBiogen Inc. | 19.33 B USD | 132.03 USD | −3.52% | 1.33 M | 0.80 | 11.81 | 11.18 USD | +40.10% | 0.00% | Health technology | Buy |
 RPRXRoyalty Pharma plc | 17.97 B USD | 31.17 USD | +0.13% | 4.64 M | 0.88 | 16.25 | 1.92 USD | −24.37% | 2.73% | Finance | Strong buy |
 ITCIIntra-Cellular Therapies Inc. | 14.05 B USD | 131.87 USD | −0.04% | 15.53 M | 10.58 | — | −0.72 USD | +50.50% | 0.00% | Health technology | Neutral |
 SMMTSummit Therapeutics Inc. | 13.87 B USD | 18.80 USD | −2.54% | 2.78 M | 1.38 | — | −0.31 USD | +80.00% | 0.00% | Health technology | Strong buy |
 UTHRUnited Therapeutics Corporation | 13.78 B USD | 306.88 USD | −0.45% | 562.43 K | 1.22 | 12.48 | 24.60 USD | +24.00% | 0.00% | Health technology | Buy |
 INSMInsmed Incorporated | 13.03 B USD | 72.00 USD | −5.62% | 2.72 M | 1.89 | — | −5.59 USD | −4.45% | 0.00% | Health technology | Strong buy |
 BMRNBioMarin Pharmaceutical Inc. | 12.96 B USD | 67.94 USD | −3.89% | 1.28 M | 0.80 | 30.89 | 2.20 USD | +152.46% | 0.00% | Health technology | Buy |
 ILMNIllumina, Inc. | 12.42 B USD | 78.39 USD | −1.20% | 1.83 M | 0.86 | — | −7.72 USD | −5.17% | 0.00% | Health technology | Buy |
 GMABGenmab A/SDR | 12.34 B USD | 18.66 USD | −4.70% | 1.79 M | 1.47 | 10.65 | 1.75 USD | +82.11% | 0.00% | Health technology | Buy |
 INCYIncyte Corporation | 11.79 B USD | 60.91 USD | +0.59% | 2.56 M | 1.09 | 224.59 | 0.27 USD | −89.75% | 0.00% | Health technology | Buy |
 NBIXNeurocrine Biosciences, Inc. | 10.67 B USD | 107.00 USD | −3.25% | 1.74 M | 1.52 | 32.51 | 3.29 USD | +35.43% | 0.00% | Health technology | Buy |
 MRNAModerna, Inc. | 10.48 B USD | 27.16 USD | −4.20% | 11.59 M | 1.35 | — | −9.28 USD | +25.17% | 0.00% | Health technology | Neutral |
 VTRSViatris Inc. | 10.27 B USD | 8.60 USD | −1.26% | 9.23 M | 0.49 | — | −0.53 USD | −1,358.49% | 5.51% | Health technology | Buy |
 EXELExelixis, Inc. | 10.18 B USD | 36.39 USD | −1.44% | 2.79 M | 0.96 | 20.53 | 1.77 USD | +173.87% | 0.00% | Health technology | Buy |
 ASNDAscendis Pharma A/SDR | 9.33 B USD | 151.43 USD | −2.84% | 575.1 K | 1.70 | — | −7.13 USD | +22.96% | 0.00% | Health technology | Strong buy |
 MEDPMedpace Holdings, Inc. | 9.07 B USD | 297.73 USD | −2.28% | 612.8 K | 1.63 | 23.57 | 12.63 USD | +42.34% | 0.00% | Commercial services | Buy |
 TEMTempus AI, Inc. | 8.13 B USD | 47.22 USD | −2.11% | 7.61 M | 0.72 | — | −4.75 USD | −195.58% | 0.00% | Technology services | Buy |
 HALOHalozyme Therapeutics, Inc. | 7.64 B USD | 61.87 USD | −3.04% | 1.41 M | 0.82 | 18.02 | 3.43 USD | +62.77% | 0.00% | Health technology | Buy |
 JAZZJazz Pharmaceuticals plc | 7.59 B USD | 124.99 USD | +0.68% | 1.28 M | 0.81 | 14.37 | 8.70 USD | +50.71% | 0.00% | Health technology | Strong buy |
 MDGLMadrigal Pharmaceuticals, Inc. | 7.15 B USD | 323.98 USD | −2.19% | 262.26 K | 1.13 | — | −22.11 USD | −10.89% | 0.00% | Health technology | Strong buy |
 ROIVRoivant Sciences Ltd. | 7.03 B USD | 9.85 USD | −2.38% | 8.8 M | 1.01 | — | −0.14 USD | −102.78% | 0.00% | Health technology | Strong buy |
 BBIOBridgeBio Pharma, Inc. | 6.28 B USD | 33.02 USD | −4.48% | 2.81 M | 1.12 | — | −2.85 USD | +27.90% | 0.00% | Health technology | Strong buy |
 RVMDRevolution Medicines, Inc. | 6.25 B USD | 33.62 USD | −4.92% | 2.71 M | 2.20 | — | −3.57 USD | +5.49% | 0.00% | Health technology | Strong buy |
 LEGNLegend Biotech CorporationDR | 6.23 B USD | 31.52 USD | −7.10% | 2.2 M | 2.42 | — | −0.97 USD | +67.21% | 0.00% | Health technology | Strong buy |
 SRPTSarepta Therapeutics, Inc. | 6.01 B USD | 61.91 USD | −2.99% | 3.53 M | 0.98 | 25.97 | 2.38 USD | — | 0.00% | Health technology | Buy |
 GRFSGrifols, S.A.DR | 5.54 B USD | 6.96 USD | −2.11% | 1.24 M | 1.30 | — | — | — | 0.00% | Health technology | Neutral |
 BPMCBlueprint Medicines Corporation | 5.49 B USD | 85.94 USD | −2.90% | 1.3 M | 1.24 | — | −1.07 USD | +87.20% | 0.00% | Health technology | Buy |
 AXSMAxsome Therapeutics, Inc. | 5.45 B USD | 111.67 USD | −4.25% | 1.67 M | 2.89 | — | −6.00 USD | −15.29% | 0.00% | Health technology | Strong buy |
 VRNAVerona Pharma plcDR | 5.37 B USD | 58.54 USD | −7.80% | 2.23 M | 2.54 | — | −2.16 USD | −213.94% | 0.00% | Health technology | Strong buy |
 ALKSAlkermes plc | 5.29 B USD | 32.53 USD | −1.48% | 1.43 M | 0.86 | 14.92 | 2.18 USD | +5.35% | 0.00% | Health technology | Buy |
 GHGuardant Health, Inc. | 5.24 B USD | 42.47 USD | −0.31% | 1.37 M | 0.81 | — | −3.56 USD | +16.91% | 0.00% | Health services | Strong buy |
 KRYSKrystal Biotech, Inc. | 5.03 B USD | 174.58 USD | −3.17% | 307.49 K | 1.21 | 58.43 | 2.99 USD | +3,261.08% | 0.00% | Health technology | Strong buy |
 NUVLNuvalent, Inc. | 4.87 B USD | 68.00 USD | −4.12% | 1 M | 2.10 | — | −3.91 USD | −81.09% | 0.00% | Health technology | Strong buy |
 ADMAADMA Biologics Inc | 4.61 B USD | 19.42 USD | −2.12% | 2.22 M | 0.60 | 23.99 | 0.81 USD | — | 0.00% | Health technology | Strong buy |
 CYTKCytokinetics, Incorporated | 4.44 B USD | 37.50 USD | −6.69% | 2.26 M | 1.21 | — | −5.28 USD | +3.20% | 0.00% | Health technology | Strong buy |
 IONSIonis Pharmaceuticals, Inc. | 4.33 B USD | 27.26 USD | −9.65% | 3.01 M | 2.12 | — | −3.04 USD | −18.79% | 0.00% | Health technology | Buy |
 PCVXVaxcyte, Inc. | 4.15 B USD | 32.23 USD | −14.65% | 8.83 M | 3.90 | — | −3.88 USD | +7.75% | 0.00% | Health technology | Strong buy |
 ZLABZai Lab LimitedDR | 4.01 B USD | 37.29 USD | +3.18% | 2.01 M | 2.21 | — | −2.60 USD | +24.92% | 0.00% | Health technology | Strong buy |
 PTCTPTC Therapeutics, Inc. | 3.68 B USD | 46.60 USD | −8.56% | 2.88 M | 3.38 | — | −4.73 USD | +43.51% | 0.00% | Health technology | Buy |
 ACLXArcellx, Inc. | 3.34 B USD | 60.70 USD | −7.47% | 1.06 M | 1.75 | — | −1.99 USD | −31.69% | 0.00% | Health technology | Strong buy |
 RNAAvidity Biosciences, Inc. | 3.21 B USD | 26.74 USD | −9.42% | 2.46 M | 1.57 | — | −2.90 USD | +0.17% | 0.00% | Health technology | Strong buy |
 RYTMRhythm Pharmaceuticals, Inc. | 3.16 B USD | 50.00 USD | −5.61% | 653.2 K | 1.18 | — | −4.36 USD | −35.93% | 0.00% | Health technology | Strong buy |
 SWTXSpringWorks Therapeutics, Inc. | 3.14 B USD | 41.88 USD | −5.10% | 2.59 M | 1.56 | — | −3.48 USD | +30.06% | 0.00% | Health technology | Strong buy |
 RAREUltragenyx Pharmaceutical Inc. | 3.13 B USD | 33.84 USD | −6.55% | 992.73 K | 1.39 | — | −6.34 USD | +23.93% | 0.00% | Health technology | Strong buy |
 AKROAkero Therapeutics, Inc. | 3.08 B USD | 38.64 USD | −4.55% | 1.79 M | 1.84 | — | −3.75 USD | −31.37% | 0.00% | Health technology | Strong buy |
 PTGXProtagonist Therapeutics, Inc. | 2.88 B USD | 46.88 USD | −3.06% | 1.05 M | 0.86 | 11.15 | 4.21 USD | — | 0.00% | Health technology | Strong buy |
 CRNXCrinetics Pharmaceuticals, Inc. | 2.85 B USD | 30.62 USD | −8.71% | 2.2 M | 1.94 | — | −3.70 USD | −0.12% | 0.00% | Health technology | Strong buy |
 APLSApellis Pharmaceuticals, Inc. | 2.85 B USD | 22.68 USD | +3.70% | 4.53 M | 1.96 | — | −1.60 USD | +64.32% | 0.00% | Health technology | Buy |
 SRRKScholar Rock Holding Corporation | 2.85 B USD | 30.06 USD | −6.50% | 2.15 M | 1.68 | — | −2.57 USD | −22.34% | 0.00% | Health technology | Strong buy |
 CRSPCRISPR Therapeutics AG | 2.84 B USD | 33.14 USD | −2.62% | 2.11 M | 1.14 | — | −4.36 USD | −121.15% | 0.00% | Health technology | Buy |
 MRUSMerus N.V. | 2.74 B USD | 39.60 USD | −5.92% | 1.73 M | 2.51 | — | −3.32 USD | −10.95% | 0.00% | Health technology | Strong buy |
 ACADACADIA Pharmaceuticals Inc. | 2.72 B USD | 16.32 USD | −1.75% | 2.02 M | 1.35 | 12.00 | 1.36 USD | — | 0.00% | Health technology | Buy |
 HCMHUTCHMED (China) LimitedDR | 2.67 B USD | 16.06 USD | +6.78% | 368.87 K | 3.78 | 74.32 | 0.22 USD | −62.40% | 0.00% | Health technology | Strong buy |
 IMVTImmunovant, Inc. | 2.58 B USD | 15.20 USD | −11.06% | 3.63 M | 1.30 | — | −2.62 USD | −43.10% | 0.00% | Health technology | Strong buy |
 AMRXAmneal Pharmaceuticals, Inc. | 2.58 B USD | 8.23 USD | −1.79% | 2 M | 1.19 | — | −0.38 USD | −21.58% | 0.00% | Health technology | Strong buy |
 ALVOAlvotech | 2.57 B USD | 9.64 USD | −0.31% | 180.8 K | 1.26 | — | −0.85 USD | +59.22% | 0.00% | Health technology | Buy |
 IBRXImmunityBio, Inc. | 2.53 B USD | 2.96 USD | −1.66% | 6.36 M | 0.96 | — | −0.63 USD | +43.89% | 0.00% | Health technology | Strong buy |
 FOLDAmicus Therapeutics, Inc. | 2.44 B USD | 7.95 USD | −2.57% | 2.98 M | 0.98 | — | −0.18 USD | +64.39% | 0.00% | Health technology | Buy |
 XENEXenon Pharmaceuticals Inc. | 2.35 B USD | 30.64 USD | −8.67% | 1.12 M | 2.81 | — | −3.01 USD | −10.19% | 0.00% | Health technology | Strong buy |
 TWSTTwist Bioscience Corporation | 2.32 B USD | 38.94 USD | −0.82% | 1.12 M | 1.30 | — | −3.38 USD | +6.06% | 0.00% | Health technology | Buy |
 VCYTVeracyte, Inc. | 2.3 B USD | 29.56 USD | −0.30% | 684.07 K | 0.77 | 96.44 | 0.31 USD | — | 0.00% | Health technology | Buy |
 VCELVericel Corporation | 2.16 B USD | 43.09 USD | −3.44% | 421.17 K | 1.02 | 233.40 | 0.18 USD | — | 0.00% | Health technology | Strong buy |
 MIRMMirum Pharmaceuticals, Inc. | 2.16 B USD | 44.04 USD | −2.24% | 405.34 K | 0.92 | — | −1.85 USD | +53.98% | 0.00% | Health technology | Strong buy |
 APGEApogee Therapeutics, Inc. | 2.12 B USD | 35.61 USD | −4.68% | 664.71 K | 0.95 | — | −3.23 USD | −94.92% | 0.00% | Health technology | Strong buy |
 RXRXRecursion Pharmaceuticals, Inc. | 2.05 B USD | 5.10 USD | −3.69% | 16.84 M | 1.08 | — | −1.66 USD | −6.86% | 0.00% | Health technology | Buy |
 TARSTarsus Pharmaceuticals, Inc. | 2.04 B USD | 48.92 USD | −4.77% | 688.23 K | 0.90 | — | −3.10 USD | +33.12% | 0.00% | Health technology | Strong buy |
 NAMSNewAmsterdam Pharma Company N.V. | 2.02 B USD | 18.38 USD | −10.21% | 2.59 M | 2.39 | — | −2.60 USD | −1,203.87% | 0.00% | Health technology | Strong buy |
 LGNDLigand Pharmaceuticals Incorporated | 2.02 B USD | 104.82 USD | −0.30% | 97.78 K | 0.74 | — | −0.15 USD | −105.31% | 0.00% | Health technology | Strong buy |
 NVCRNovoCure Limited | 1.93 B USD | 17.52 USD | −1.68% | 598.07 K | 0.90 | — | −1.56 USD | +19.76% | 0.00% | Health technology | Strong buy |
 EWTXEdgewise Therapeutics, Inc. | 1.92 B USD | 20.13 USD | −8.50% | 1.31 M | 0.88 | — | −1.45 USD | +7.97% | 0.00% | Health technology | Strong buy |
 CNTACentessa Pharmaceuticals plcDR | 1.91 B USD | 13.23 USD | −8.00% | 1.38 M | 1.35 | — | −1.99 USD | −25.86% | 0.00% | Health technology | Strong buy |
 HRMYHarmony Biosciences Holdings, Inc. | 1.86 B USD | 32.42 USD | −2.32% | 581.85 K | 0.72 | 12.92 | 2.51 USD | +17.72% | 0.00% | Health technology | Strong buy |
 DNLIDenali Therapeutics Inc. | 1.78 B USD | 12.29 USD | −9.60% | 2.89 M | 2.44 | — | −2.58 USD | −136.50% | 0.00% | Health technology | Strong buy |
 ARQTArcutis Biotherapeutics, Inc. | 1.78 B USD | 14.98 USD | −4.22% | 1.46 M | 0.60 | — | −1.16 USD | +70.23% | 0.00% | Health technology | Strong buy |
 SUPNSupernus Pharmaceuticals, Inc. | 1.77 B USD | 31.68 USD | −3.27% | 608.39 K | 1.07 | 24.03 | 1.32 USD | — | 0.00% | Health technology | Buy |
 BEAMBeam Therapeutics Inc. | 1.76 B USD | 17.64 USD | −9.70% | 4.35 M | 1.93 | — | −4.58 USD | −139.89% | 0.00% | Health technology | Strong buy |
 CGONCG Oncology, Inc. | 1.68 B USD | 22.05 USD | −9.96% | 1.2 M | 1.45 | — | −1.16 USD | — | 0.00% | Health technology | Strong buy |
 ARWRArrowhead Pharmaceuticals, Inc. | 1.68 B USD | 12.21 USD | −4.20% | 1.73 M | 0.96 | — | −5.15 USD | −85.82% | 0.00% | Health technology | Buy |
 GLPGGalapagos NVDR | 1.66 B USD | 24.77 USD | −1.39% | 183.57 K | 1.30 | 20.61 | 1.20 USD | — | 0.00% | Health technology | Neutral |
 KYMRKymera Therapeutics, Inc. | 1.64 B USD | 25.24 USD | −7.80% | 1.43 M | 2.60 | — | −2.97 USD | −17.79% | 0.00% | Health technology | Strong buy |
 IRONDisc Medicine, Inc. | 1.63 B USD | 47.15 USD | −5.02% | 610.64 K | 1.50 | — | −3.99 USD | −14.19% | 0.00% | Health technology | Strong buy |
 JANXJanux Therapeutics, Inc. | 1.58 B USD | 26.81 USD | −0.70% | 1.19 M | 1.63 | — | −1.28 USD | +4.61% | 0.00% | Health technology | Strong buy |
 KNSAKiniksa Pharmaceuticals, Ltd. | 1.58 B USD | 21.77 USD | −1.98% | 435.89 K | 0.83 | — | −0.61 USD | −430.93% | 0.00% | Health technology | Strong buy |
 DVAXDynavax Technologies Corporation | 1.58 B USD | 12.71 USD | −2.00% | 1.82 M | 0.93 | 72.75 | 0.17 USD | — | 0.00% | Health technology | Buy |
 AGIOAgios Pharmaceuticals, Inc. | 1.57 B USD | 27.40 USD | −6.48% | 934.89 K | 1.51 | 2.40 | 11.40 USD | — | 0.00% | Health technology | Buy |
 MESOMesoblast LimitedDR | 1.55 B USD | 11.90 USD | −4.65% | 259.46 K | 1.00 | — | −0.93 USD | +12.87% | 0.00% | Health technology | Strong buy |
 TVTXTravere Therapeutics, Inc. | 1.55 B USD | 17.44 USD | −2.68% | 2.1 M | 1.26 | — | −4.10 USD | +10.01% | 0.00% | Health technology | Strong buy |
 BCRXBioCryst Pharmaceuticals, Inc. | 1.51 B USD | 7.25 USD | −3.33% | 2.25 M | 0.78 | — | −0.43 USD | +63.50% | 0.00% | Health technology | Strong buy |
 MNKDMannKind Corporation | 1.5 B USD | 4.95 USD | −1.59% | 2.88 M | 1.64 | 54.10 | 0.09 USD | — | 0.00% | Health technology | Strong buy |
 IMCRImmunocore Holdings plcDR | 1.49 B USD | 28.63 USD | −3.51% | 859.63 K | 2.67 | — | −1.03 USD | +10.05% | 0.00% | Health technology | Buy |